Literature DB >> 16222611

Diabetes, insulin resistance and vascular disease among Indian Asians and Europeans.

John C Chambers1, Jaspal S Kooner.   

Abstract

Indian Asians account for one-fifth of all cardiovascular deaths worldwide. Cardiovascular mortality in Indian Asians overseas is higher than in indigenous populations. Diabetes, insulin resistance, and related metabolic disturbances are more common among Indian Asians than Europeans and may account for up to 70% of major Q wave ECG abnormalities in Asians. Previous studies provide evidence that genetic and environmental factors, the latter including intrauterine growth retardation, reduced physical activity, increased weight, and dietary intake, contribute to the high prevalence of diabetes and insulin resistance in Asians. The importance of conventional coronary risk factors is emphasized by studies showing higher prevalence of cigarette smoking, hypertension, and hypercholesterolemia in migrant and urban Indians compared with rural Indians. Recent studies suggest that new risk factors, including C-reactive protein, homocysteine, and lipoprotein(a), are increased among Indian Asians compared with Europeans and may contribute to part of the excess cardiovascular risk in Asians. Further work is needed to identify the precise genetic and environmental mechanisms underlying increased vascular risk in Indian Asians. Clinical strategies must be developed that identify Indian Asians at increased risk and assess the effectiveness of treatment for insulin resistance, and other cardiovascular risk factors, in this racial group.

Entities:  

Mesh:

Year:  2002        PMID: 16222611     DOI: 10.1055/s-2002-32043

Source DB:  PubMed          Journal:  Semin Vasc Med        ISSN: 1528-9648


  7 in total

Review 1.  Dyslipidemia in special ethnic populations.

Authors:  Jia Pu; Robert Romanelli; Beinan Zhao; Kristen M J Azar; Katherine G Hastings; Vani Nimbal; Stephen P Fortmann; Latha P Palaniappan
Journal:  Cardiol Clin       Date:  2015-05       Impact factor: 2.213

2.  A genome-wide analysis of admixture in Uyghurs and a high-density admixture map for disease-gene discovery.

Authors:  Shuhua Xu; Li Jin
Journal:  Am J Hum Genet       Date:  2008-08-28       Impact factor: 11.025

Review 3.  Effectiveness of physical activity and dietary interventions in South Asian populations: a systematic review.

Authors:  Janine Chapman; Nadeem Qureshi; Joe Kai
Journal:  Br J Gen Pract       Date:  2013-02       Impact factor: 5.386

Review 4.  Dyslipidemia in Special Ethnic Populations.

Authors:  Jia Pu; Robert Romanelli; Beinan Zhao; Kristen M J Azar; Katherine G Hastings; Vani Nimbal; Stephen P Fortmann; Latha P Palaniappan
Journal:  Endocrinol Metab Clin North Am       Date:  2016-03       Impact factor: 4.741

5.  Renal function and risk factors of moderate to severe chronic kidney disease in Golestan Province, northeast of Iran.

Authors:  Iraj Najafi; Fatemeh Attari; Farhad Islami; Ramin Shakeri; Fatemeh Malekzadeh; Rasool Salahi; Mina Yapan Gharavi; Mostafa Hosseini; Behrooz Broumand; Ali Nobakht Haghighi; Bagher Larijani; Reza Malekzadeh
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

6.  Multi-center feasibility study evaluating recruitment, variability in risk factors and biomarkers for a diet and cancer cohort in India.

Authors:  Rashmi Sinha; Carrie R Daniel; Niveditha Devasenapathy; Hemali Shetty; Susan Yurgalevitch; Leah M Ferrucci; Preethi S George; Kerry Grace Morrissey; Lakshmy Ramakrishnan; Barry I Graubard; Kavita Kapur; K Srinath Reddy; Mary J McAdams; Tanuja Rastogi; Nilanjan Chatterjee; Prakash C Gupta; Sholom Wacholder; Dorairaj Prabhakaran; Aleyamma A Mathew
Journal:  BMC Public Health       Date:  2011-05-27       Impact factor: 3.295

7.  Effect of oral cinnamon intervention on metabolic profile and body composition of Asian Indians with metabolic syndrome: a randomized double -blind control trial.

Authors:  Sonal Gupta Jain; Seema Puri; Anoop Misra; Seema Gulati; Kalaivani Mani
Journal:  Lipids Health Dis       Date:  2017-06-12       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.